Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466245
Status:
COMPLETED
Last Update Posted:
2014-01-22
First Post:
2007-04-25
Brief Title:
Phase 2 Study of Safety Tolerability and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine
Sponsor:
Organization:
Sanofi